Skip to main content
. 2022 Mar 18;13:862394. doi: 10.3389/fendo.2022.862394

Figure 6.

Figure 6

(A) Representative photomicrographs of NF-κB/p56 immuno-stained cardiac sections from different experimental groups, ×200 bar 50. (B) A graph showing immunoreactive score for NF-κB/p56 cellular expression. Data are represented as mean ± SE, n = 6. **** significance in comparison with control group at p < 0.0001, #### significance in comparison with diabetic group at p < 0.0001, ~~~~ significance in comparison with DM+Dapa at p < 0.0001, $$$ significance in comparison with DM+Lira group at p < 0.001. (C) A graph showing immunoreactive score for NF-κB/p56 differentially in the nucleus and cytoplasm. Data are expressed as mean ± SEM (n = 6). **** p < 0.0001 versus control, #### p < 0.0001, ### p < 0.001 versus diabetic group and p < 0.0001, @ p < 0.05 versus DM+Dapa for nuclear expression, ΔΔp < 0.01, ΔΔΔΔp < 0.0001 versus control, ΦΦ p < 0.01 versus diabetic group, πππp < 0.001 versus DM+Dapa for cytoplasmic expression. Dapa, dapagliflozin; Lira, liraglutide.